Scilex receives $20.4M from Armistice warrant exercise; issues new warrants for 1.36M shares

Scilex Holding Co

Existing warrants (904,396 shares) exercised at reduced price $22.51/share, gross proceeds $20.36M.
New unregistered warrants issued for 1,356,594 shares at $29.00 strike, 5-year term.
Placement agents to receive 8% cash fee and warrants for 72,352 shares.
Company to file resale registration statement for new warrant shares within 45 days.
Investor previously held warrants with exercise prices of $38.50 and $22.72.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Scilex Holding Co issued up to an aggregate of 1,356,594 shares of Common Stock of warrant to a certain institutional investor for reduction of the exercise price of the Existing Warrants to $22.51 per share.

Security: warrant
Shares: up to an aggregate of 1,356,594 shares of Common Stock
Purchaser: a certain institutional investor
Consideration: reduction of the exercise price of the Existing Warrants to $22.51 per share

Exact text from the filing

the Company agreed to (i) reduce the exercise price of the Existing Warrants to $22.51 per share and (ii) issue to the Investor a new unregistered warrant (the “November 2025 Warrant”) to purchase up to an aggregate of 1,356,594 shares of Common Stock with an exercise price of $29.00 per share (the “Exercise Price”) in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933 (the “Securities Act”).

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Scilex Holding Co issued up to an aggregate of 72,352 shares of Common Stock of warrant to the placement agents or their designees for cash fee equal to 8.0% of the aggregate gross proceeds from the Exercise and to reimburse certain expenses.

Security: warrant
Shares: up to an aggregate of 72,352 shares of Common Stock
Purchaser: the placement agents or their designees
Consideration: cash fee equal to 8.0% of the aggregate gross proceeds from the Exercise and to reimburse certain expenses

Exact text from the filing

Company and StockBlock, dated as of March 22, 2024 (as amended and supplemented from time to time, the “Engagement Agreement”), the Company has agreed to pay a cash fee equal to 8.0% of the aggregate gross proceeds from the Exercise and to reimburse certain expenses. The Company has also agreed to issue the placement agents or their designees, warrants to

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Scilex Holding Co entered into Warrant Inducement Agreement with a certain institutional investor (effective 2025-11-23).

Action: entry
Agreement: equity purchase
Counterparty: a certain institutional investor
Effective: 2025-11-23

Exact text from the filing

On November 23, 2025, Scilex Holding Company, (the “Company”) entered into a warrant inducement agreement (the “Warrant Inducement Agreement”) with a certain institutional investor (the “Investor”)

View on SEC.gov

Browse all equity issuances →

Scilex Holding Co filing history →

Source: SEC EDGAR

accession 0001193125-25-293861

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.